Management Team

Tim Willis

Tim Willis

CHIEF EXECUTIVE OFFICER

Tim Willis

CHIEF EXECUTIVE OFFICER

Tim Willis

CHIEF EXECUTIVE OFFICER

Tim has worked in Dry Eye for more than 15 years. In that time, he developed the Soothe XP artificial tear product currently marketed by Bausch and Lomb. He helped develop and license Systane Balance to Alcon. Most recently, he was the founder, inventor, and CEO of TearScience, a medtech company started to diagnose and treat Meibomian Gland Dysfunction, the leading cause of Dry Eye. During his tenure at TearScience he raised $134M in funding, approved 4 products for the diagnosis and treatment of evaporative dry eye and launched them in over 30 countries and obtained regulatory clearance in over 50 countries. TearScience was acquired by Johnson and Johnson. Tim holds a BS in Electro-Mechanical Engineering and is a fellow of the American Academy of Optometry.

Ralph Stone, PhD

Ralph Stone, PhD

CHIEF TECHNOLOGY OFFICER

Ralph Stone, PhD

CHIEF TECHNOLOGY OFFICER

Ralph Stone, PhD

CHIEF TECHNOLOGY OFFICER

Dr. Stone was the VP of Consumer R&D at Alcon/Novartis where he developed and launched over 15 ophthalmic products including the Systane® dry eye artificial tear product line. A PhD chemist by training, Ralph has 35 years of ophthalmic R&D experience and is a recognized FDA expert in the field of ophthalmology. Ralph holds degrees from Middlebury and Bowdoin was well as a Ph.D. in Chemistry from the University of Vermont.

Joe Huber

Joe Huber

CHIEF OPERATING OFFICER

Joe Huber

CHIEF OPERATING OFFICER

Joe Huber

CHIEF OPERATING OFFICER

Joe has a decade of experience developing, financing, and launching early stage medical technologies. As a product manager at Midmark Corporation, he was responsible for the full lifecycle of a portfolio of dental, anesthesia, and vital signs devices, which saw years of profitable double-digit growth. Joe has since worked with startups in the device and consumer sectors, was a fellow at an early-stage venture capital fund, and interned at Silicon Valley Bank’s Bay Area Life Science Practice. Joe has a BS from the University of Louisville and received his MBA from Duke University’s Fuqua School of Business.

Diethart Reichardt

Diethart Reichardt

CHIEF MARKETING OFFICER & BOARD MEMBER

Diethart Reichardt

CHIEF MARKETING OFFICER & BOARD MEMBER

Diethart Reichardt

CHIEF MARKETING OFFICER & BOARD MEMBER

Diethart is the former President of Allergan’s Consumer/OTC Products division, a global business focused on contact lenses, contact lens care, ocular lubricants, and dry eye products. During his  35 years there, he managed businesses of all stages, including capital equipment, disposables and medical devices, as well as pharmaceuticals and OTC products.

Kent Geer

Kent Geer

CHIEF FINANCIAL OFFICER

Kent Geer

CHIEF FINANCIAL OFFICER

Kent Geer

CHIEF FINANCIAL OFFICER

Mr. Geer is a former partner with Ernst & Young. Kent has more than 30 years of experience and track record serving numerous public and private companies in a variety of industries including biotechnology, medical device, pharmaceuticals and other technology companies. During his tenure, Mr. Geer was the audit practice leader for Ernst & Young Entrepreneurial Services Group and was the market team leader for the technology industry practice. Kent holds a BS in Business from UNC Chapel Hill and is a CPA.

Advisors

Charles Hamner, DVM, PhD

Charles Hamner, DVM, PhD

Known as the “Biofather of North Carolina”, Dr. Hamner served as the President of The NC Biotechnology Center. He is credited with building the thriving Biotech industry that drives the Triangle’s economy. Dr. Hamner, in working with several foundations and pharmaceutical companies, developed 22 pharmaceutical products currently on the market, 15 of which are OTC products.

Alan N. Carlson, MD

Alan N. Carlson, MD

Dr. Carlson serves as Duke University Vice Chair of Departmental Development and Professor and former Chairman of Ophthalmology specializing in cataract, refractive, and corneal surgery. Dr. Carlson was selected among the top 6 refractive surgeons in university settings. His innovative work has been featured in publications such as Time Magazine, Reader’s Digest, and RedBook.

Edward J. Holland, MD

Edward J. Holland, MD

Dr. Holland is the Director of Cornea Services at Cincinnati Eye Institute and Professor of Ophthalmology at the University of Cincinnati. He formerly served as the President for the American Society of Cataract and Refractive Surgery from 2011-2012. He was also a member of the Executive Committee and now serves as the Program Chair. Dr. Holland was a former member of the Board of Trustees for the American Academy of Ophthalmology. He has also served on numerous committees and as the Secretariat of the Annual Meeting for the American Academy of Ophthalmology. Dr. Holland has served as the Chair of the Eye Bank Association and was the former Chair of the Medical Advisory Board as well as a longtime member of the Board of Directors. He is the past President of the Cornea Society and previously served many years on its Board of Directors.

Michael Christensen, OD, PhD, FAAO

Michael Christensen, OD, PhD, FAAO

With decades of experience in Industry, Academia and Private Practice. Christensen is an expert on the tear film and ocular surface. He has dozens of publications and led Alcon’s clinical trial programs for Dry Eye. He is a Senior Fellow of the American Academy of Optometry.

Michael S. Korenfeld, MD, ACOS

Michael S. Korenfeld, MD, ACOS

Dr. Michael S. Korenfeld, MD, ACOS is a Board Certified ophthalmologist. Dr. Korenfeld is a Founding Member of ACOS, and was inducted because of his 20 years of performing FDA clinical trials (over 30 in dry eye) and his ophthalmic surgical inventions, which are used in operating rooms around the world.

Management Team

Tim Willis

Tim Willis

CHIEF EXECUTIVE OFFICER

Tim Willis

CHIEF EXECUTIVE OFFICER

Tim Willis

CHIEF EXECUTIVE OFFICER

Tim has worked in Dry Eye for more than 15 years. In that time, he developed the Soothe XP artificial tear product currently marketed by Bausch and Lomb. He helped develop and license Systane Balance to Alcon. Most recently, he was the founder, inventor, and CEO of TearScience, a medtech company started to diagnose and treat Meibomian Gland Dysfunction, the leading cause of Dry Eye. During his tenure at TearScience he raised $134M in funding, approved 4 products for the diagnosis and treatment of evaporative dry eye and launched them in over 30 countries and obtained regulatory clearance in over 50 countries. TearScience was acquired by Johnson and Johnson. Tim holds a BS in Electro-Mechanical Engineering and is a fellow of the American Academy of Optometry.

Ralph Stone, PhD

Ralph Stone, PhD

CHIEF TECHNOLOGY OFFICER

Ralph Stone, PhD

CHIEF TECHNOLOGY OFFICER

Ralph Stone, PhD

CHIEF TECHNOLOGY OFFICER

Dr. Stone was the VP of Consumer R&D at Alcon/Novartis where he developed and launched over 15 ophthalmic products including the Systane® dry eye artificial tear product line. A PhD chemist by training, Ralph has 35 years of ophthalmic R&D experience and is a recognized FDA expert in the field of ophthalmology. Ralph holds degrees from Middlebury and Bowdoin was well as a Ph.D. in Chemistry from the University of Vermont.

Joe Huber

Joe Huber

CHIEF OPERATING OFFICER

Joe Huber

CHIEF OPERATING OFFICER

Joe Huber

CHIEF OPERATING OFFICER

Joe has a decade of experience developing, financing, and launching early stage medical technologies. As a product manager at Midmark Corporation, he was responsible for the full lifecycle of a portfolio of dental, anesthesia, and vital signs devices, which saw years of profitable double-digit growth. Joe has since worked with startups in the device and consumer sectors, was a fellow at an early-stage venture capital fund, and interned at Silicon Valley Bank’s Bay Area Life Science Practice. Joe has a BS from the University of Louisville and received his MBA from Duke University’s Fuqua School of Business.

Diethart Reichardt

Diethart Reichardt

CHIEF MARKETING OFFICER & BOARD MEMBER

Diethart Reichardt

CHIEF MARKETING OFFICER & BOARD MEMBER

Diethart Reichardt

CHIEF MARKETING OFFICER & BOARD MEMBER

Diethart is the former President of Allergan’s Consumer/OTC Products division, a global business focused on contact lenses, contact lens care, ocular lubricants, and dry eye products. During his  35 years there, he managed businesses of all stages, including capital equipment, disposables and medical devices, as well as pharmaceuticals and OTC products.

Kent Geer

Kent Geer

CHIEF FINANCIAL OFFICER

Kent Geer

CHIEF FINANCIAL OFFICER

Kent Geer

CHIEF FINANCIAL OFFICER

Mr. Geer is a former partner with Ernst & Young. Kent has more than 30 years of experience and track record serving numerous public and private companies in a variety of industries including biotechnology, medical device, pharmaceuticals and other technology companies. During his tenure, Mr. Geer was the audit practice leader for Ernst & Young Entrepreneurial Services Group and was the market team leader for the technology industry practice. Kent holds a BS in Business from UNC Chapel Hill and is a CPA.

Advisors

Charles Hamner, DVM, PhD

Charles Hamner, DVM, PhD

Known as the “Biofather of North Carolina”, Dr. Hamner served as the President of The NC Biotechnology Center. He is credited with building the thriving Biotech industry that drives the Triangle’s economy. Dr. Hamner, in working with several foundations and pharmaceutical companies, developed 22 pharmaceutical products currently on the market, 15 of which are OTC products.

Alan N. Carlson, MD

Alan N. Carlson, MD

Dr. Carlson serves as Duke University Vice Chair of Departmental Development and Professor and former Chairman of Ophthalmology specializing in cataract, refractive, and corneal surgery. Dr. Carlson was selected among the top 6 refractive surgeons in university settings. His innovative work has been featured in publications such as Time Magazine, Reader’s Digest, and RedBook.

Edward J. Holland, MD

Edward J. Holland, MD

Dr. Holland is the Director of Cornea Services at Cincinnati Eye Institute and Professor of Ophthalmology at the University of Cincinnati. He formerly served as the President for the American Society of Cataract and Refractive Surgery from 2011-2012. He was also a member of the Executive Committee and now serves as the Program Chair. Dr. Holland was a former member of the Board of Trustees for the American Academy of Ophthalmology. He has also served on numerous committees and as the Secretariat of the Annual Meeting for the American Academy of Ophthalmology. Dr. Holland has served as the Chair of the Eye Bank Association and was the former Chair of the Medical Advisory Board as well as a longtime member of the Board of Directors. He is the past President of the Cornea Society and previously served many years on its Board of Directors.

Michael Christensen, OD, PhD, FAAO

Michael Christensen, OD, PhD, FAAO

With decades of experience in Industry, Academia and Private Practice. Christensen is an expert on the tear film and ocular surface. He has dozens of publications and led Alcon’s clinical trial programs for Dry Eye. He is a Senior Fellow of the American Academy of Optometry.

Michael S. Korenfeld, MD, ACOS

Michael S. Korenfeld, MD, ACOS

Dr. Michael S. Korenfeld, MD, ACOS is a Board Certified ophthalmologist. Dr. Korenfeld is a Founding Member of ACOS, and was inducted because of his 20 years of performing FDA clinical trials (over 30 in dry eye) and his ophthalmic surgical inventions, which are used in operating rooms around the world.

OFfice

5650 Six Forks Rd. Suite 202 Raleigh, NC 27609